Related Laws Explorer

Requires local and regional boards of education to maintain a supply of epinephrine auto-injectors for use in schools.

Requires restaurants to display food allergy awareness posters and school districts to implement updated food allergy management plans.

Allows pharmacists to prescribe and dispense epinephrine cartridge injectors to patients with a prior prescription and requires insurance coverage for the devices.

Elijah's Law

Requires the state to establish a comprehensive anaphylaxis policy for all childcare facilities. It mandates the development of emergency protocols, including guidelines for weight-based epinephrine administration, staff training, and individual emergency healthcare plans for children with known allergies.

Epinephrine Modernization Act

Amends existing school health laws to clarify that 'epinephrine' includes both auto-injectable devices and nasal spray formats, ensuring schools can stock modern delivery methods for treating anaphylaxis.

Massachusetts Stock Epinephrine Bill

This pending bill would require all schools to maintain a stock supply of non-patient specific epinephrine auto-injectors. It mandates that the Department of Public Health create regulations for storage in unlocked locations and staff training.

Epinephrine Delivery Systems Update

A pending bill that updates existing school health statutes to replace the term 'epinephrine auto-injectors' with 'epinephrine delivery systems.' This change is intended to allow schools to stock newer, needle-free epinephrine options such as nasal sprays.

School Epinephrine Administration Expansion Bill

Legislative bill to explicitly codify into the General Laws the authority for school districts and non-public schools to register to train unlicensed school personnel to administer epinephrine auto-injectors during school hours and school-sponsored events when a nurse is not immediately available.

Elijah's Law

Establishes 'Elijah's Law' for Missouri, requiring licensed child care facilities to adopt allergy prevention and emergency response policies, and explicitly adds child care facilities to authorized entities allowed to acquire and stock epinephrine auto-injectors.

HELP Copays Act

Bans copay accumulator adjustment policies that prevent manufacturer copay assistance from counting toward patient deductibles and out-of-pocket maximums.

SponsorSen. Roger Marshall (R-KS) (Bipartisan)

Safe Step Act

Requires group health plans to establish a transparent exceptions process (24-72 hours) for step therapy protocols, allowing doctors to override insurer fail-first requirements when medically necessary.

SponsorSen. Tammy Baldwin (D-WI), Rep. Lucy McBath (D-GA) (Bipartisan)

Chronic Disease Flexible Coverage Act

Expands coverage options for individuals with chronic diseases including asthma by allowing states to offer targeted chronic disease coverage plans outside of traditional open enrollment.

New York Asthma Inhaler Coverage Act (S.3100A)

S.3100A expands New York insurance coverage for the treatment of asthma to include a second rescue and maintenance inhaler, along with any medically necessary devices for children. New Yorkers with asthma can face large financial barriers to drugs that hinder optimal treatment; high out-of-pocket costs hinder adherence, threaten patient health, and exacerbate health disparities. The bill passed the Senate 59-2 on March 17, 2025 and was reported and committed to the Finance Committee on May 12, 2026.

Federal bill to cap the cost of life-saving epinephrine injectors by establishing cost-sharing requirements under group health plans and health insurance coverage.

Requires private health insurers to provide epinephrine products without deductibles, copayments, or coinsurance.